Pernilla Sundqvist

Örebro University

Papers

1

Total Citations

9

H-Index

1

About

Dr. Pernilla Sundqvist is a leading urologic oncologist whose research focuses on renal tumor management and the standardization of treatment protocols across Nordic healthcare systems. As a founding member of the Nordic Renal Cancer Group (NORENCA), she has been instrumental in fostering cross-border collaboration to improve outcomes for kidney cancer patients. Her most cited work, the NORENCA-I study (2017), surveyed contemporary treatment practices for renal tumors across Denmark, Finland, Iceland, Norway, and Sweden, revealing critical variations in surgical approaches and surveillance strategies. This landmark paper, with 9 citations, provided the foundational data needed to harmonize clinical guidelines and launched a series of influential follow-up studies. Dr. Sundqvist’s contributions have directly shaped evidence-based practice in nephron-sparing surgery and active surveillance, impacting thousands of patients across the Nordic region. Her dedication to collaborative research and quality improvement continues to drive innovation in renal cancer care, making her a respected voice in European urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study)
9 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Örebro University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago